XTL Biopharmaceuticals Ltd. ADR | Balance Sheet
Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
10,100.60
8,483.40
15,828.80
9,363.80
21,156.20
30,349.90
Total Accounts Receivable
1,711.20
276.30
533.10
735.10
93.70
82.20
Inventories
1,048.20
-
-
-
-
-
Other Current Assets
4,803.90
3,389.50
233.50
500.30
295.10
190.60
Total Current Assets
17,663.90
12,149.10
16,595.30
10,599.20
21,545.10
30,622.70
Net Property, Plant & Equipment
211.70
93.40
42.80
38.50
-
-
Total Investments and Advances
-
-
38.90
-
-
-
Intangible Assets
9,944.40
9,720.80
4,035.00
973.70
1,319.20
1,420
Total Assets
27,820.10
21,963.30
20,712.10
11,611.40
22,864.30
32,042.60
Accounts Payable
2,134.70
844.40
459.10
65.40
13.90
Other Current Liabilities
2,096.50
2,910.80
1,237.40
1,204.60
1,027.60
Total Current Liabilities
4,231.10
3,755.20
1,696.50
1,270.10
1,041.50
Provision for Risks & Charges
38.20
-
-
-
-
Other Liabilities
-
-
-
-
9,258.90
Total Liabilities
4,269.30
3,755.20
1,696.50
1,270.10
10,300.40
Common Equity (Total)
21,745.80
18,134.20
19,015.60
10,341.30
12,563.90
Total Shareholders' Equity
21,745.80
18,134.20
19,015.60
10,341.30
12,563.90
Total Equity
23,550.70
18,208.10
19,015.60
10,341.30
12,563.90
Liabilities & Shareholders' Equity
27,820.10
21,963.30
20,712.10
11,611.40
22,864.30
Accumulated Minority Interest
1,804.90
73.90
-
-
-
About XTL Biopharmaceuticals
View Profile
